US Drug Recall Register
Class II · Moderate risk Terminated Initiated Mar 21, 2024 (2 years ago)

Rifampin Capsules USP, 300mg, 30-count bottles, Rx only, Manufactured for: Lupin…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Subpotent Drug

What was recalled

Rifampin Capsules USP, 300mg, 30-count bottles, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, Manufactured by: Lupin Limited Aurangabad 431 210 India, NDC 6818-0659-06

Recalling firm
Lupin Pharmaceuticals Inc.
NDC code
6818-0659-06
Origin
MD, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0437-2024

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Rifampin recalls

See all